Attached files
Exhibit 32.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
The undersigned, Gergely Toth, the Chief Executive Officer of
Cantabio Pharmaceuticals Inc. (the “Company”) hereby
certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his or
her knowledge, the Report on Form 10-Q of Cantabio Pharmaceuticals
Inc., for the quarterly period ended December 31, 2017 fully
complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934, and that the information contained
in the Report on Form 10-Q fairly presents in all material respects
the financial condition and results of operations of Cantabio
Pharmaceuticals Inc.
Date: February 20, 2018
/s/Gergely Toth
By: Gergely
Toth
Chief Executive Officer